VIDEO: Decellularized amniotic membrane an option for neurotrophic keratitis

MIAMI — In this video from Sunshine Eye & Retina, Neel R. Desai, MD, discusses access to treatment options for neurotrophic keratitis.
Patients may have trouble accessing Oxervate (cenegermin-bkbj, Dompé), but according to Desai, other treatments are available, including decellularized amniotic membrane.
“Many times, we will place a Biovance 3L membrane (DefEYE) on a patient with stage 1, stage 2 or even stage 3 [neurotrophic keratitis], and we’re finding that by the time Oxervate has been approved, they don’t need it anymore,” Desai, of the Eye Institute of



